WEREWOLF THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $23.00K, a 1050.00% increase year-over-year.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $12.00K.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $2.00K, a 97.85% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $7.00K, a 96.88% decline from fiscal 2022.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $224.00K, a 4.68% decline from fiscal 2021.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $235.00K, a 803.85% increase from fiscal 2020.
- WEREWOLF THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $26.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $35.00K S-4 · filed 2026-09-22 | |
| 2024-09-30 | $23.00K 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $12.00K 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $7.00K 10-K · filed 2025-03-11 | |
| 2023-09-30 | $2.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $5.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $224.00K 10-K · filed 2024-03-07 | |
| 2022-09-30 | $93.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $1.00K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $129.00K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $235.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $26.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $131.00K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $21.00K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $26.00K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $4.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |